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Abstract
Thimet oligopeptidase (EP24.15) is a cysteine-rich metallopeptidase containing fifteen Cys residues and no intra-protein
disulfide bonds. Previous work on this enzyme revealed that the oxidative oligomerization of EP24.15 is triggered by S-
glutathiolation at physiological GSSG levels (10–50 mM) via a mechanism based on thiol-disulfide exchange. In the present
work, our aim was to identify EP24.15 Cys residues that are prone to S-glutathiolation and to determine which structural
features in the cysteinyl bulk are responsible for the formation of mixed disulfides through the reaction with GSSG and, in
this particular case, the Cys residues within EP24.15 that favor either S-glutathiolation or inter-protein thiol-disulfide
exchange. These studies were conducted by in silico structural analyses and simulations as well as site-specific mutation. S-
glutathiolation was determined by mass spectrometric analyses and western blotting with anti-glutathione antibody. The
results indicated that the stabilization of a thiolate sulfhydryl and the solvent accessibility of the cysteines are necessary for
S-thiolation. The Solvent Access Surface analysis of the Cys residues prone to glutathione modification showed that the S-
glutathiolated Cys residues are located inside pockets where the sulfur atom comes into contact with the solvent and that
the positively charged amino acids are directed toward these Cys residues. The simulation of a covalent glutathione docking
onto the same Cys residues allowed for perfect glutathione posing. A mutation of the Arg residue 263 that forms a saline
bridge to the Cys residue 175 significantly decreased the overall S-glutathiolation and oligomerization of EP24.15. The
present results show for the first time the structural requirements for protein S-glutathiolation by GSSG and are consistent
with our previous hypothesis that EP24.15 oligomerization is dependent on the electron transfer from specific protonated
Cys residues of one molecule to previously S-glutathionylated Cys residues of another one.
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Introduction
Thimet oligopeptidase (EC3.4.24.15; EP24.15) is a thiol-rich
metallopeptidase ubiquitously distributed in mammalian cells
[1,2]. EP24.15 has been shown to play an important intracellular
role in the degradation of peptides released by the 26 S
proteasome [3–7]. The enzyme is prone to oxidative oligomeri-
zation through the formation of interprotein disulfides involving
specific Cys residues [8,9]. It possesses 15 Cys residues and no
intra-protein S-S bond. We had already demonstrated that
EP24.15 is modified both in vivo and in vitro by S-glutathiolation
and that the formation of intermolecular oxidative crosslinking
and subsequent oligomerization is triggered by S-glutathiolation
[10]. Moreover, as demonstrated by experiments performed in
vitro, EP24.15 S-glutathiolation is needed for full peptidase activity.
In conclusion, EP24.15 seems to undergo a dynamic mechanism
of thiol-disulfide exchange through S-glutathiolation, and the
GSSG concentrations necessary to S-glutathiolate EP24.15 and
trigger its oligomerization was 10 mM, compatible with GSSG
concentrations found in intracellular compartments.
The mixed disulfides of glutathione with proteins (termed
protein S-glutathiolation) are observed in many functional
conditions, and they accumulate in the mitochondria and cytosol
of cells upon oxidative challenge [11]. Protein S-glutathiolation
has been proposed as an anti-oxidative defense by protecting
either the protein Cys residues from over oxidation or the GSH
intracellular pool. Moreover, the S-glutathiolation that occurs
during enzyme catalysis and redox signaling has been increasingly
accepted as a post-translational protein modification that is
dependent on intracellular redox shifts, thereby regulating anti-
oxidative cellular responses independent of the global oxidative
challenge [11,12].
There are many mechanisms proposed for protein S-
glutathiolation, although most of them were only demonstrated
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39408
5in vitro [13]. Mechanisms taking place in vivo are still poorly
explored. The oxidation of protein Cys residues in sulfenic acid
(Cys-SOH) and the subsequent S-glutathiolation of the sulfenic
form by the reduced glutathione pool during enzyme catalysis
and specific redox signaling have been accepted as commonly
occurring events in redox regulation [14–19]. On the other
hand, protein S-glutathiolation, through the oxidized glutathione
species, is thought to be achieved only when the intracellular
GSSG pool is increased, which, in turn, occurs upon oxidative
stress as the GSSG pool is maintained by cells at low levels
under homeostasis [13]. Examples reported in the literature are
based on protein S-glutathiolation by the GSSG and are usually
related to protein inactivation [11]. In these studies, proteins are
usually incubated in vitro with high concentrations of GSSG,
which would mimic an intense oxidative stressing condition
inside cells. Other mechanisms of protein S-glutathiolation have
been proposed, such as those resulting from the formation of
protein thiyl radicals, followed by the reaction with GSH, and
from the S-nitrosoglutathione (GSNO) reaction with the protein
sulfhydryl [11,20]. In fact, the mechanism of S-glutathiolation is
dictated by the nature of the protein; in the case of EP24.15, its
S-glutathiolation was observed at GSSG concentration as low as
10 mM, compatible with the intracellular milieu in homeostasis
conditions [10].
Protein S-glutathiolation depends on the thiol reactivity, pKa
and solvent accessibility. The reaction of GSSG with protein
thiolate ions (-S
-) occurs much more readily than with
protonated groups (–SH). On the other hand, the formation
and stabilization of protein thiolate ions is usually associated
with the presence of positively charged groups in the vicinity of
the thiol group [21,22].
Our starting point in the present work was based on previously
conducted studies [10]. Those studies revealed that EP24.15 S-
glutathiolation by GSSG concentrations as low as 10 mM occurs
concomitantly to its oligomerization to the dimer and primarily
trimer protein forms. Conversely, using higher concentrations of
GSSG (0.5–5 mM), EP24.15 was highly S-glutathiolated and
remained in its monomeric form [10]. On the basis of those
results, we proposed a mechanism for oligomerization that is
dependent on S-glutathiolation at low GSSG concentrations,
which would trigger oligomerization through inter-protein thiol/
disulfide exchange. Nonetheless, when the number of S-glutathio-
lated Cys residues was increased (by increasing the GSSG:EP24.15
molar ratio), the protein lost its ability for oligomerization.
Notably, when EP24.15 was incubated with H2O2 and then
treated with GSH, it was not S-glutathiolated. Instead, intrapro-
tein disulfide bonds were observed. Thus, the EP24.15 Cys
residues that are prone to S-glutathiolation are very reactive
toward GSSG.
In the present work, EP24.15 was used as a model to conduct
studies searching for protein structural features that might trigger
Cys thiolation by GSSG. To accomplish this goal, our approach
was first to identify by mass spectrometry EP24-15 S-glutathio-
lated Cys residues after the incubation of TCEP-reduced protein
at a GSSG concentration that concomitantly induces glutathiola-
tion and oligomerization (e.g.,5 0mM) and at 1 mM, a concentra-
tion at which glutathiolation is increased and oligomerization is
inhibited. Afterward, in silico GRID and covalent GSH docking to
the protein Cys residues were utilized to analyze the solvent
accessibility of the Cys residues and to predict the glutathione
docking. Finally, a site-specific mutation was utilized to validate
some of our findings.
Materials and Methods
Reagents
DTT (dithiothreitol), GSSG (oxidized glutathione), and TCEP
[Tris (2-carboxy-ethyl) phosphine hydrochloride] were purchased
from SIGMA. Anti-GSH antibody was obtained from Virogen
and Arbor Assays. Anti-EP24.15 antibody was obtained from
Proteimax. Bradford protein assay reagent was purchased from
Bio-Rad. All other reagents were of analytical grade.
Site-directed Mutagenesis
Site-directed mutagenesis of testis rat EP24.15 was performed in
pGEX-4t2 (Amersham-Pharmacia Biotech Inc.) using the proto-
cols described by the manufacturer of the Quick-change Site-
directed mutagenesis kit (Stratagene, Inc). Oligonucleotide primers
59 GAG CTA GTG TCC CTG GAG GCG CAG AAG TCC
AAC 39 (sense) and 59 GTT GGA CTT CTG CGC CTC CAG
GGA CAC TAG CTC 39 (antisense) were used to introduce the
R263E point mutation on EP24.15. The plasmid DNA was
purified (Mini-Prep, Promega Corp.) and mutations were screened
by automatic DNA sequencing, using a MegaBace machine (GE
Healthcare). Plasmid DNA containing the desired mutation was
purified (Mini-Prep, Promega Corp.), transformed into electro-
competent Escherichia coli BL21 cells and plated overnight on plates
containing ampicillin to yield single colonies.
Expression and Purification of Recombinant EP24.15:
Wild Type and R263E Mutant
Recombinant proteins (wild type and mutant) were expressed in
E. coli (XL1-blue or BL21; Stratagene) as glutathione-S-transferase
(GST) fusion proteins using the expression vector pGEX-4T2
(Amersham Biosciences). Protein purification was initially con-
ducted by affinity chromatography using a glutathione-Sepharose
column (Amersham Biosciences) with the respective proteins
released from the GST-fusion by cleavage with thrombin
(100 U; Amersham Biosciences). Further purification was per-
formed by concentrating the samples in membranes (Millipore,
Bedford, MA, USA) with nominal molecular exclusion limits of
50 kDa. The purity of the proteins was analyzed by Coomassie
brilliant blue staining after 8% SDS-PAGE. After confirming
homogeneity larger than 95% (data not shown), aliquots of
proteins were stored at 280uC.
MS Analyses
After purification and GSSG treatment, the proteins (wild type
or the mutant) were subjected to SDS-PAGE. The band of interest
was excised from the gel, and after destaining the proteins,
EP24.15 was digested with Trypsin Gold (Promega), according to
the manufacturer’s protocol. The digested products were re-
covered and then desalted with C-18 ZipTip resin (Millipore).
Another approach was to treat the proteins with GSSG and then
perform tryptic digestion. The tryptic fragments were analyzed by
LC-MS/MS following separation by reverse-phase HPLC. The
additional mass of one glutathione molecule to the cysteine-
containing fragments (+305.1 Da) was determined by using the
Thermo Finnigan LTQ ion trap mass spectrometer at Instituto de
Quı ´mica – Proteomics Core Facility, UNICAMP, Campinas-SP,
Brazil.
Immunoassays
Immunoblots were performed as described by the protocol
enclosed in the ECL
TM Western Blotting Systems (GE Bios-
ciences). Membranes were incubated with horseradish-peroxidase-
S-glutathiolation and Oxidative Oligomerization
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detected using enhanced chemiluminescence Western Blotting
Detection Reagents (Amersham Biosciences). The dilutions of the
antibodies were as follows: 1:2000 (anti-EP24.15) and 1:1000 (anti-
GSH). Loading controls were evaluated by anti-EP24.15 when S-
glutathiolation was determined as well as by Ponceau S staining.
Reduction and S-glutathiolation of EP24.15
Preparations of purified recombinant EP24.15 (500–900 mg),
the wild type or the mutant protein were incubated with 10 mM
TCEP, a specific sulfhydryl reductant. After incubation, protein
preparations were filtered through Microcon YM-50 microfilters
(Millipore) to completely remove the remaining TCEP by 3–4
cycles of filtration and redilution. Aliquots of these preparations
were incubated in the presence of GSSG at indicated concentra-
tions. After measuring the protein concentration, aliquots of
reduced and S-glutathionylated protein preparations were used for
MS or immunoblot analyses.
Determination of Protein Concentration
Protein concentrations were calculated by taking the theoretical
e280 of EP24.15 (78,240/M deduced by the ExPASy ProtParam
tool (http://www.expasy.ch/tools/protparam.html). Bradford re-
agent was utilized for protein determination as well, using bovine
serum albumin (BSA) as a protein standard.
GRID Methodology
GRID is a fully automated computational method [23,24]. The
3D structure of the human thimet oligopeptidase 24.15 was used
for the GRID analyses, since the rat EP24.15 3D structure is not
available. The identity between both sequences, human and rat, is
89%, and nearly all of the cysteine residues are conserved (Fig. S1).
The human EP24.15 structure was obtained from the PDB file
1S4B (resolution 2.0 A ˚), and this structure was considered to be
the structure for the wild type protein with no further modifica-
tions. Crystal water molecules and ions were removed. The
structure of R263E mutant was prepared in the Biopolymer
module of the Sybyl 8.0 (Tripos) program (SYBYL, Version 7.0.
Saint Louis - USA: Tripos Inc; Copyright 1991–2004, 2004). The
side chains of mutant residues were placed in their lowest energy
position and were allowed to minimize their energies using the
Tripos force field, with Pullman charges and conjugate gradient
minimization, keeping all other protein residues rigid.
Wild type and mutant proteins were placed on GRID boxes,
and the molecular interaction fields were calculated for each
protein using the SH probe (neutral thiol group), as already
described [23,24]. A cubic (10 A ˚ 3) molecular grid was centered on
Cys175, with a grid spacing of 0.11 A ˚. Minimum energy positions
of the SH probe around the Cys175 residue of the wild type and
R263E mutant were examined and compared.
Molecular Dynamics
The 3D structure of human thimet oligopeptidase EP24.15 is
available as PDB file 1S4B (resolution 2.0 A ˚). This structure lacks
both N- and C-terminal tails. The C-terminal sequence consists of
10 residues (678-QVEGCEPPAC) and is present in the rat thimet
oligopeptidase EP24.15. Because this terminal tail sequence
contains two important cysteine residues, a model of this sequence
was added to the structure of the human thimet oligopeptidase
EP24.15. The rat sequence composed of residues QVEGCEPPAC
was added to the Leu677 terminal residue of the human EP24.15.
This addition was performed using the Biopolymer module of the
Sybyl 8.0 (Tripos) program (SYBYL, Version 7.0., Tripos Inc;
Copyright 1991–2004, 2004). Minimization of the added tail
sequence was carried out by the Tripos force field using another
module of the Sybyl 8.0 program. A molecular dynamics script
was then used to simulate the positioning of this tail sequence on
the top of human EP24.15. Molecular Dynamics (MD) simulations
were performed using the GROMACS5 3.3.3 package with the
standard GROMOS96 force field G43a15. Simulations were
performed at constant temperature and pressure in a box filled
with SPC water molecules by using periodic boundary conditions.
The net charge of EP24.15 was compensated by adding three Na
+
ions. The simulation included 218,640 atoms. The temperature
was kept constant at 300 K using the Berendsen thermostat. The
particle mesh Ewald method (PME) was used for electrostatic
calculations. A non-bonded cutoff of 0.9 nm for Lennard-Jones
potential was used. Simulations of covalent hydrogen bonds were
delimited by the Shake algorithm. A time step of 2 fs was used.
Simulations started with the structure of the human EP24.15, as
described in 1S4B, with the added C-terminal 10-residues tail, as
described above. Initially, the solvent was relaxed by energy
minimization, followed by 15 ps of MD at 300 K, while
restraining protein atomic positions with a harmonic potential.
Then, the whole system was subjected to minimization by steepest
descent and conjugate gradient methods without restraints, and an
MD was started by raising the temperature to 300 K by heating
the solvent to 300 K over a period of 25 ps. This step was followed
by a period of 100 ps for equilibration. Production runs were
started at 300 K and simulated for 5 ns. Energy data were stored
every 10 time steps, and atomic coordinate values for the entire
trajectory recorded were stored every 2 ps.
Structural Analysis
Solvent accessible surface area (SAS; relative and absolute) was
calculated for the selected cysteine residues of human thimet
oligopeptidase 24.15 using the structure PDB 1S4B with no water
molecules or ions. Relative SAS values are the surface areas of the
cysteineresidueintheproteinrelativetothatfortheexposedresidue
in the tripeptide Ala-Cys-Ala. In addition, interatomic distances
between the SG (sulfur atom) of Cys residues and any positively
charged atom up to a 10 A ˚ distance were calculated. All of these
calculations wereperformed usingthe Sybyl 8.0(Tripos) program.
Covalent Docking
The tripeptide glutathione (GSH) was covalently docked onto
the 3D structure of human thimet oligopeptidase EP24.15, using
the structure PDB 1S4B with no water molecules or ions. This
simulation was carried out using Gold, version 5.0, with GA
settings similar to those for noncovalent docking and all of the
other default docking settings. The results were scored using the
Goldscore function. The covalent docking option was chosen,
determining that the SG sulfur atom from each of the selected
EP24.15 cysteine residues had to be bound to the sulfur atom of
glutathione and thus form a disulfide bond between the protein
and the ligand. The hydrogen atom bond to the sulfur atom of
GSH was removed so that the sulfur atom would not exceed its
valence. Ten possible solutions were then obtained. We avoided
the automated procedure by turning off the option for the
termination of the docking. We had the option of allowing the
generation of different structures that were visually evaluated.
Results
Identification of EP24.15 S-glutathiolated Cys Residues
The first step was to identify by mass spectrometry (MS) the Cys
residues prone to S-thiolation by incubating the TCEP-reduced
S-glutathiolation and Oxidative Oligomerization
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According to the results obtained, five Cys residues were modified
(by the addition of 305.1 mass units) after incubation with 1 mM
GSSG. The same residues were reduced after TCEP treatment
(spectra of C175 and C246 are shown in Fig. 1A and C,
respectively). As depicted in Table 1, the S-glutathiolated Cys
residues were C46, C175, C246, C682 and C687. Residues C46,
C175 and C246 were also S-glutathiolated after incubation with
50 mM GSSG. In addition to the five modified Cys, two fragments
containing unmodified Cys residues were found after 1 mM
GSSG treatment, residues 427 and 434, as shown in Table 1. The
remaining eight Cys were not identified after protein incubation
with 1 mM GSSG. The Q-ToF analysis was conducted three
times with the 1 mM GSSG-incubated protein. Four of these eight
residues (C177; C231; C248 and C253) were detected after TCEP
treatment in two out four of the experiments performed. Two
other reduced Cys residues (C7 and C18) were detected in one of
the experiments, where EP24.15 was treated with 50 mM GSSG.
We also searched for other possible sulfhydryl modifications, such
as -SOH, SO2H and SO3H, in all of the fragments containing Cys
residues predicted. No other modification was observed, except for
the –SH and the –S-SG forms. Figure 1 shows representative
spectra of the C175- and C-246-containing fragments generated
after EP24.15 incubation with TCEP and 50 mM GSSG.
Figure 1. Spectra representative of Q-ToF analyses. The spectra shown were obtained after trypsin-hydrolysis of EP24.15 incubated with TCEP,
followed or not by treatment with 1 mM GSSG, and refer to the fragments containing the C175 and C246 residues as follows: (A) and (C) after TCEP-
treatment, respectively; (B) and (D) after incubation of the TCEP-reduced protein with 1 mM GSSG, respectively.
doi:10.1371/journal.pone.0039408.g001
Table 1. EP24.15 fragments containing S-glutathiolated Cys
residues generated by trypsin hydrolysis and followed by Q-
ToF analysis.
Cys location Mr(calc) Delta Sequence
46
1 2186.03 20.02 R.ALTTQLIEQTKCVYDR.V
175
1 1625.79 0.00 K.RLSLLCIDFNK.N
246
1 1554.69 20.00 R.RLLEEAFNCR.C
682 and 687 1811.65 20.00 K.GLQVEGCEPPAC
427 and 434 1591.74 20.04 K.YGHAACFGLQPGCLR.Q
The wild type protein was treated with TCEP followed by 1 mM GSSG, as
described in the Materials and Methods. Next, samples were digested with
trypsin for Q-TOF analysis.
Sequence coverage was 63%. Underlined and italic Cys notations were S-
glutathiolated and reduced, respectively. Fragments containing the other eight
EP24.15 Cys residues were not detected in this condition; those containing
oxidized Cys residues to –SOH, SO2H or –SO3H were also investigated and not
detected. Representative Q-ToF spectra detecting 305.1 mass additions are
shown in Figure 1.
1The same residues were also S-glutathiolated after incubation with 50 mM
GSSG.
doi:10.1371/journal.pone.0039408.t001
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Residues in the 3D-EP24.15 Structure
The five Cys residues that were S-glutathiolated after incubation
with 1 mM GSSG (C46, C175, C246, C682 and C687), the two
residues that were reduced (C427 and C434) and the other six Cys
residues were analyzed for their Solvent Access Surface (SAS) and
for their interactions established with charged residues in the 3D
protein structure. The calculated parameters from eight Cys
residues are shown in Table 2. According to the parameters
analyzed, common to the five S-glutathiolated Cys residues were
either the high SAS or the presence of K or R residues close to the
Cys-sulfur atom in the 3D structure. The two reduced Cys residues
were found to have low or null SAS and no positively charged
amino acid in the vicinity of the cysteine (Table 2). Among the
other eight Cys residues, only C253 presents high SAS (37.5) when
compared to the SAS obtained among the S-glutathiolated Cys.
Moreover, a Lys residue was detected, whose charge is a 7.7 A ˚
distance from C253-sulfur atom, the highest found among the S-
glutathiolated Cys residues to any positive charge (Table 2). In
addition, fragments containing the C253 residue were not detected
by the Q-ToF analysis, even in the TCEP-treated protein, and, as
discussed next, the GSH covalent docking to C253 was not
allowed.
The data discussed above indicate that high SAS together in the
presence of positively charged residues close to the sulfur atom of
Cys residues were common and exclusive to the Cys residues that
were S-glutathiolated.
Covalent Glutathione Docking
In another set of analyses, the covalently attached glutathione
(GS) was docked to Cys residues. The five S-glutathiolated Cys
residues analyzed (C46, C175, C246, C682 and C687) exhibited
pockets in the EP24.15 structure that perfectly accommodated the
GSH molecule (Fig. 2A–E). In all of the five cases examined, the
glutathione posing was accomplished through polar interactions
between the GSH N-terminus and a protein hydrogen acceptor
(indicated by arrows), and the distance calculated between the
hydrogen acceptor and the Cys-sulfur atom was 1162A ˚ (3A-E) in
all cases. As illustrated in Fig. 3A, which depicts GSH bonded to
Cys46, the GSH N-terminus is 1.5 A ˚ from the backbone oxygen of
Ser63. The same polar interaction was observed in the case of the
GSH bonded to Cys175 where the GSH N-terminal is 1.7 A ˚ from
the backbone oxygen of Gly604 (Fig. 3B). In the cases of GSH
bonded to Cys246 and Cys687 (Fig. 3C and E, respectively), the
GSH N-terminus interacts (distances 1.8–3.0 A ˚) with the negative
charge on residues Asp185, Glu502 and Cys687 (carboxy
terminal). Finally, the N-terminal end of GSH bonded to
Cys682 makes two polar contacts of 2.4 and 2.0 A ˚ with the
residues Ser651 and Leu650, respectively (Fig. 3D). On the other
hand, GSH covalent docking was not allowed in the other nine
Cys residues analyzed. The residues C427 and C434 were not S-
glutathiolated, because these residues cannot accommodate a GSH
molecule in their particular protein bulks and they are not
accessible to the solvent (Table 2).
Our major conclusion from the data discussed so far is that the
S-glutathiolation of the EP24.15 by GSSG is either dependent on
Cys residues’ accessibility to the solvent or on the interaction of the
cysteine sulfur atom with a positively charged residue. Moreover,
the existence of adequate protein pockets, including hydrogen
acceptors for GS-posing, was common to all of the S-glutathio-
lated Cys residues analyzed.
Site Specific Mutation
As already known, the Cys thiolate specie is considered much
more prone to S-glutathiolation than the protonated thiol because
of its higher nucleophilic driving [22,25]. The formation and
stabilization of a given thiolate depends on the thiol pKa, which in
turn is determined by the protein folding. Depending on Cys
residue location into the protein core, the formation and
stabilization of the thiolate could be facilitated, in most cases, by
a lysine or an arginine residue [25,26].
Taking the considerations above into account, in the next step,
we performed a site-specific mutation of the residue R263
identified as potentially responsible for the maintenance of the
thiolate species in the C175 residue selected for the study.
Afterward, the ability of EP24.15 mutant protein to undergo S-
glutathiolation and oligomerization in the presence of increasing
Table 2. Cys residues were analyzed according to their Solvent Access Surface (SAS) and distance of the Cys-sulfur atom from
positively charged residues.
Cys Glutathiolation
1 SAS
2
Positive residue
3 Distance
4 (A ˚)
Relative
5 Absolute (A ˚ 2)
046 Yes 0.70 64.0 Arg - 050 5.0
175 Yes 0.25 24.0 Arg - 263 3.5
246 Yes 0.25 22.0 Lys - 249 5.8
427 No 0.04 3.5 No –
434 No 0.00 0.0 Arg - 436 7.5
682 Yes 0.35 32.5 No _
687 Yes 1.00 91 Lys-677 7.7
253 No 0.30 37.5 Lys-249 7.7
The methodology of the analyses performed is described in the Materials and Methods.
1According to MS analyses.
2Solvent Access Surface.
3Positively charged residues identified as close to Cys residues shown in the first column.
4Distance between positive charge and the Cys sulfur atom.
5The fractional values (Relative) are the surface areas of the residues relative to those of the exposed residue in the tripeptide Ala-X-Ala, where X is the residue of
interest.
doi:10.1371/journal.pone.0039408.t002
S-glutathiolation and Oxidative Oligomerization
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39408Figure 2. Glutathione covalent docking on EP24.15 surface. The 3D-EP24.15 structure focusing S-glutathiolated Cys residues is surface
represented and the glutathione (GSH) molecule by sticks. The Cys-sulfur, nitrogen and oxygen atoms are highlighted in yellow, blue and red,
respectively. Arrows indicate protein hydrogen-acceptors. Their distance to the protein Cys-sulfur atom is shown in A (white line) and was the same in
all other S-glutathiolated Cys residues (B – E).
doi:10.1371/journal.pone.0039408.g002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39408Figure 3. Glutathione interactions to EP24.15 Cys residues. The 3D-EP24.15 structure focusing S-glutathiolated Cys residues is represented by
ribbons and the glutathione (GSH) molecule by sticks. The Cys-sulfur, nitrogen and oxygen atoms are highlighted in yellow, blue and red,
respectively. The distances (A ˚) of major GSH interactions to EP24.15 residues are highlighted (dashed lines).
doi:10.1371/journal.pone.0039408.g003
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procedure, the interaction between C175 and the mutated residue
was analyzed and compared to the wild type protein.
The C175 residue is located on the surface of the EP24.15
catalytic cleft (Figure 4) and exposed to the solvent. As observed
previously, EP24.15 catalytic activity is modulated by S-glutathio-
lation [10]. The calculated distance between C175 and the R263
residue was 3.5 A ˚ (Fig. 2S and Table 2), compatible to a saline
type interaction [27] favoring the thiolate form of C175. Thus, we
chose to mutate the R263 residue to an E residue. Our idea was to
completely inhibit any possibility of the formation/stabilization of
the C175 thiolate ion.
GRID Analyses with the R263 Mutant
The calculated distance between the E263 and C175 residues
was 6.8 A ˚, as compared to 3.5 A ˚ for the wild type protein (not
shown). Data from the GRID studies on the energies of molecular
interaction calculated for the SH probe on the wild type protein
and R263E mutant showed that the interaction between the probe
and C175 residue was more favorable (27.8 kcal/mol) for the wild
type protein than for the mutated protein (26.2 kcal/mol). On the
other hand, the covalent docking between GSH and C175 that
was favored in the wild type protein (Fig. 2B) was also possible in
the mutant protein studied (not shown).This result means that
neither the Arg residue nor the mutated counterpart are necessary
for the interactions established to allow GSH covalent docking to
the C175 residue.
Experimental Data with the R263E Mutant
Next, experimental assays were performed, showing that
EP24.15 S-glutathiolation was greatly reduced in the mutated
protein when compared to the wild type protein (Fig. 5). The
R263E mutant protein only exhibited S-glutathiolation when
incubated at 100 mM GSSG, and this result was reproduced three
times. Data obtained on EP24.15 oligomerization revealed that
the R263E mutant protein oligomerizes only at GSSG concentra-
tions as high as 100 mM (Figure 6). This result is in agreement with
the S-glutathiolation data for the mutant protein (Fig. 5).
The S-glutathiolation of the R263E mutant protein was also
analyzed by Q-ToF, after incubation with 1 mM GSSG. Among
the five residues that were S-glutathiolated in the wild type protein
at same GSSG concentration, only the C246 residue was S-
glutathiolated in the mutant protein, though all the fragments
containing the remaining four Cys residues were detected.
Altogether, these results indicate that Cys175 likely lost much of
its reactivity toward GSSG as a result of the R263 residue
mutation, according to the data obtained from the MS analysis.
Moreover, the mutated protein does not oligomerize at the same
concentrations where the wild type protein oligomerizes, which is
in agreement with our proposed mechanism (10). These results
Figure 4. 3D-EP24.15 structure. The figure highlights as follows: the five S-glutathiolated Cys residues (46, 175, 246, 682 and, 687; pink); the two
reduced Cys residues (427 and 434; blue) identified by MS analyses after incubation of the TCEP-reduced protein with 1 mM GSSG, as shown in
Table 1, and the C253 residue (blue) that possesses a high SAS, as shown in Table 2. The catalytic cleft is located on the central structural core where
C175 is placed.
doi:10.1371/journal.pone.0039408.g004
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the glutathiolation of other residues in the protein. One possibility
is that the concomitant S-glutathiolation of the three most reactive
Cys residues (those glutathiolated at 50 mM GSSG: C46, 175, and
246) would change the protein structure, modifying the reactivity
of the other Cys residues for glutathiolation and oligomerization;
however, we do not have data to support this hypothesis. Other
mutations should be performed to further test this hypothesis. In
the present case, only C246 maintained its ability for glutathiola-
tion in the mutated R263E protein.
Discussion
Protein S-glutathiolation has emerged as an important post-
translational modification. In the first interpretations of the role of
this protein modification, S-glutathiolation was considered a means
of protecting cellular thiol groups (GSH and protein Cys residues)
from oxidation. More recently, it has been discovered that this
process is more widespread, capable of modifying protein structure
and function, including its role in the cellular anti-oxidative
response [11]. Even during homeostasis, cells present a constant
pool of protein mixed with disulfides that increases upon an
oxidative challenge [28]. The mechanisms of protein S-glutathio-
lation are relatively well described and demonstrated in vitro. There
is a consensus on the need for protein thiol reactivity in S-
thiolation. The reactivity is dependent on the formation of the
thiolate; thus, the process is dependent on the protein thiol pKa
(usually within two units of neutral pH). However, thiol reactivity
through nucleophilic attack to electrophiles cannot be explained
exclusively by the protein thiol pKa, as recently discussed in the
literature [21]. Either the pKa is important to increase thiolate
availability, or the thiolate reactivity toward electrophiles is
dependent on the thiol protein bulk [21]. However, the literature
indicates a lack of information on the protein structural clues that
favor glutathiolation.
The goal in the present work was to analyze the structure and
particular features that might favor protein S-glutathiolation
through GSSG. We chose the thimet oligopeptidase EP24.15 for
this purpose once we had already investigated the mechanism and
Figure 5. S-glutathiolation of the R263E mutant EP24.15. (A) Blotting shown is representative of anti-GSH labeling of the wild type and the
mutant protein after reduction with TCEP, followed by incubation with GSSG at indicated concentrations. The procedure is described in the Materials
and Methods. The loading control (anti-EP24.15) was performed by labeling identical membranes utilized for the anti-GSH assay with the anti-EP24.15
antibody. (B) The optical density (OD) of the S-glutathiolated monomeric form of EP24.15 was calculated as the percentage of the OD determined in
the anti-EP24.15 blotting, set as 100. Values shown are means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0039408.g005
Figure 6. Oligomerization of the R263E mutant EP24.15. (A) Blotting shown is representative of the anti-EP24.15 labeling of the wild and
R263E mutant protein incubated at the indicated GSSG concentrations after TCEP reduction. Samples were run on 8.5% SDS-PAGE. (B) Optical density
of the dimer and trimer forms of EP24.15. The OD of the 156 kDa and 234 kDa bands was normalized according to the OD values of the 78 kDa band
of each sample. AU, arbitrary unit. Values shown are means 6 SD of three independent experiments. *p#0.0032 and
#p#0.024 (Student’s t-test)
compared to similar WT samples.
doi:10.1371/journal.pone.0039408.g006
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undergo S-glutathiolation and concomitant oligomerization at
physiological GSSG concentrations. However, at GSSG concen-
trations higher than 100 mM, the oligomerization was inhibited,
and the S-glutathiolation was increased. On the basis of these
results, we proposed a mechanism for oligomerization through
thiol-disulfide exchanges triggered by S-glutathiolation [10].
The present results suggest that at least four prerequisites might
be required for EP24.15 glutathiolation to occur through GSSG:
(a) the solvent accessibility of the cysteinyl sulfur atom; (b) the
stabilization of a thiolate form by positively charged residues close
to the Cys; (c) an adequate structural pocket to accommodate the
glutathione molecule and (d) interaction of the glutathione
molecule with protein residues.
According to the Q-ToF analyses of the fragments generated by
trypsin hydrolysis, for the EP24.15 treated with 50 mM and 1 mM
GSSG, Cys residues 46, 175 and 246 were glutathiolated through
the lowest GSSG concentration, while after protein incubation
with the highest GSSG concentration, Cys 682 and 687 also
appeared glutathiolated. These findings, as well as the mechanism
proposed earlier [10] and previous data reported in the literature
[9], strongly indicate that Cys residues 682 and 687 are involved in
protein oligomerization. This involvement would explain why, at
1 mM GSSG concentration, the protein does not oligomerize, and
why both Cys 682 and 687 were glutathiolated. When incubation
was performed with less than 50 mM GSSG, the protein
oligomerizes, and C682 and C687 were neither glutathiolated
nor in their reduced form. It was previously demonstrated that
both Cys 682 and 687 are involved in dimer formation [9], and it
is noteworthy that both residues are located in the protein C-
terminus and are highly accessible to the solvent (Table 2).
Although both conditions favor glutathiolation, most likely the
C682 and C687 reactivity toward GSSG might be lower
compared to C46, C175 and C246, as these three Cys residues
were glutathiolated after incubation with much lower GSSG
concentrations (50 mM). The three Cys residues that were
glutathiolated at both GSSG concentrations tested (50 mM and
1 mM; residues C46, C175 and C246) did not participate in
protein oligomerization unless they had not been glutathiolated
after treatment with the lowest GSSG concentration (50 mM). Our
hypothesis is that the glutathiolation of these residues confers other
functional or structural modifications on the protein, e.g., the
catalytic activity. Therefore, the Cys 175 is located on the catalytic
cleft, and as demonstrated before [10], EP24.15 glutathiolation
through a low GSSG concentration (10–50 mM) increases the
enzyme activity. Of course, one must predict the involvement of
other Cys residues for the oligomerization process as already
determined [9]. We cannot exclude the possibility that other Cys
are involved in the protein S-glutathiolation, considering that eight
Cys-containing fragments were not detected by Q-ToF analyses
after incubating the TCEP-reduced wild type protein with 50 mM
and 1 mM GSSG and the mutant protein in all of the same
conditions.
Amazingly, the R263E mutant presented a decreased capability
of oligomerization and glutathiolation after protein incubation
with 1 mM GSSG; only the C246 was glutathiolated in the R263E
mutant, as cited before. The R263 is the only positively charged
residue close enough to C175 to allow the formation and
stabilization of a thiolate at C175. Accordingly, the GSSG
concentrations necessary for the oligomerization of the mutated
protein increased to 100 mM against 10 mM in the wild type
protein.
Taken together, the data shown herein and the discussion
presented above suggest that although some glutathiolated Cys
residues do not participate in the protein oligomerization (most
likely residues 46, 175 and 246), their S-glutathiolation appears to
be an important trigger of oligomerization. One might suggest that
the glutathiolation of those residues confers structural modifica-
tions that would facilitate oligomerization through the thiol-
disulfide exchange mechanism as proposed [10]. In the case of the
C175 residue, it appears that the inhibition of its glutathiolation
when the R263 residue was mutated was sufficient to profoundly
change the protein structure, as we observed the inhibition of the
overall glutathiolation and, as predicted, EP24.15 oligomerization.
Because protein S-glutathiolation is a reversible process and is
most likely executed by thioltransferases, especially glutaredoxins
[29], this modification is expected to participate in cellular redox
modulation, as already proposed in the case of actin polymeriza-
tion when cells are exposed to growth factors and the proteasome
role in the removal of oxidized proteins [19,30,31,32].
Supporting Information
Figure S1 Alignment between the primary sequences of
the human and rat EP24.15. Cys residues are highlighted in
yellow. Sequences were obtained from NCBI Protein Database
and alignment was performed by the BLAST tool.
(TIF)
Figure S2 EP24.15 partial view. C175 and R263 residues
and the distance between them are highlighted. Data were
obtained according to Delano, W. L. (2002) ‘‘The Pymol
Molecular Graphics System’’ Delano Scientific, San Carlos, CA,
USA. (http://www.pymol.org)
(TIF)
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